Financial Health Check: Examining LifeMD Inc (LFMD)’s Key Ratios

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

LifeMD Inc (NASDAQ: LFMD) closed the day trading at $4.21 down -5.39% from the previous closing price of $4.45. In other words, the price has decreased by -$5.39 from its previous closing price. On the day, 0.85 million shares were traded. LFMD stock price reached its highest trading level at $4.4 during the session, while it also had its lowest trading level at $4.1.

Ratios:

For a better understanding of LFMD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.65. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 0.87.

On June 05, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $12.

On November 30, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $10.Craig Hallum initiated its Buy rating on November 30, 2023, with a $10 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’24 when Galluppi Stefan bought 3,000 shares for $4.93 per share. The transaction valued at 14,790 led to the insider holds 45,449 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 181320064 and an Enterprise Value of 178915312. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.02. Its current Enterprise Value per Revenue stands at 1.004 whereas that against EBITDA is -9.964.

Stock Price History:

The Beta on a monthly basis for LFMD is 1.20, which has changed by -0.3716418 over the last 52 weeks, in comparison to a change of 0.33556926 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $12.88, while it has fallen to a 52-week low of $4.44. The 50-Day Moving Average of the stock is -19.09%, while the 200-Day Moving Average is calculated to be -42.64%.

Shares Statistics:

Over the past 3-months, LFMD traded about 511.88K shares per day on average, while over the past 10 days, LFMD traded about 469670 shares per day. A total of 38.26M shares are outstanding, with a floating share count of 34.09M. Insiders hold about 20.85% of the company’s shares, while institutions hold 37.88% stake in the company. Shares short for LFMD as of 1727654400 were 4721857 with a Short Ratio of 9.22, compared to 1724976000 on 5128585. Therefore, it implies a Short% of Shares Outstanding of 4721857 and a Short% of Float of 12.8.

Earnings Estimates

Investors are eagerly awaiting the insights provided by 6.0 analysts currently analyzing and rating the stock of LifeMD Inc (LFMD).The consensus estimate for the next quarter is -$0.04, with high estimates of $0.01 and low estimates of -$0.09.

Analysts are recommending an EPS of between -$0.42 and -$0.6 for the fiscal current year, implying an average EPS of -$0.52. EPS for the following year is -$0.04, with 6.0 analysts recommending between $0.73 and -$0.42.

Revenue Estimates

7 analysts predict $53.8M in revenue for the current quarter. It ranges from a high estimate of $55M to a low estimate of $52.5M. As of the current estimate, LifeMD Inc’s year-ago sales were $38.61MFor the next quarter, 7 analysts are estimating revenue of $57.34M. There is a high estimate of $59M for the next quarter, whereas the lowest estimate is $55.9M.

A total of 7 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $209M, while the lowest revenue estimate was $205.13M, resulting in an average revenue estimate of $206M. In the same quarter a year ago, actual revenue was $152.55MBased on 7 analysts’ estimates, the company’s revenue will be $255.86M in the next fiscal year. The high estimate is $266.5M and the low estimate is $248.07M.

Most Popular